Previous 10 | Next 10 |
2024-04-03 12:54:27 ET Gainers: ARCA biopharma ABIO +81% . Kintara Therapeutics KTRA +65% . Next.e.GO N.V. EGOX +45% . Vanda Pharmaceuticals VNDA +34% . Aurora Cannabis ( ACB ) +35% . Educational Development Corp. ( EDUC ) +29% . ...
2024-04-03 06:00:00 ET Shares of Aurora Cannabis (NASDAQ: ACB) popped last month. The cannabis producer didn't release any earnings number or announce a huge deal. Instead, it benefited from the news that the German government was proceeding with what Aurora calls a "landmark lega...
2024-04-02 09:13:33 ET More on Aurora Cannabis, Canopy Growth, etc. Aurora Cannabis: Recent Performance Improvements Are Undeniable SNDL: Cannabis Rally Loses Steam Amidst Long-Term Uncertainty Canopy Growth Is Climbing, But It Won't Last Cannabis reschedulin...
Aurora Cannabis Commends Germany's Landmark Legalization Achievement Canada NewsWire NASDAQ | TSX: ACB The Expected De-scheduling of Cannabis to Fuel Expansion of the Medical Cannabis Market in Germany EDMONTON, AB , April 1, 2024 /PRNewswire/ -- ...
A panel reviewing Canadian law on adult-use marijuana has recommended that pharmacy access be enabled for medical cannabis. This comes after Shoppers Drug Mart, the biggest pharmacy chain in the nation, requested that pharmacies be allowed to sell medical marijuana products. By doing so, pati...
2024-03-28 11:56:22 ET Summary Germany's new marijuana policies will decriminalize and effectively legalize cannabis for personal use, allowing individuals to grow and consume it at home. The new regulations include the formation of tightly regulated recreational cannabis consumpt...
2024-03-27 12:42:49 ET More on Acreage, Canopy Growth, etc. Canopy Growth Is Climbing, But It Won't Last Investors Have Another Chance To Sell Curaleaf Curaleaf: New York To The Rescue GOP committee opposes cannabis banking bill; calls marijuana 'gateway drug...
2024-03-27 07:00:00 ET Summary Aurora Cannabis shares have plummeted by over 95% in the past three years due to low demand and operational inefficiencies. The company's sales performance has declined, and its core medicinal marijuana market in Canada is not expected to experience ...
2024-03-26 11:34:10 ET More on cannabis stocks Holders Of Trulieve Should Sell It Trulieve Cannabis: Up Over 122% In 2024, But Where Does It Go Next? Trulieve's Triumph: Navigating Growth And 280E Tax In The Green Rush Americans overwhelmingly support cannabi...
2024-03-25 15:06:06 ET More on marijuana companies Investors Have Another Chance To Sell Curaleaf Curaleaf: New York To The Rescue Curaleaf: Wild Divide Between Wall Street And SA Analysts Sentiments Cannabis stocks spike as VP Kamala Harris urges immediate r...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- When it comes to investing in the legal marijuana industry, they don't call it the "green rush" for nothing. Many analysts are projecting massive growth for the cannabis industry. New Frontier, a Washington D.C.-based cannabis research firm, expects total U.S. legal cannabis s...
2024-07-18 05:30:00 ET To say Aurora Cannabis (NASDAQ: ACB) has faced some challenges over the years would be a huge understatement. The once-leading cannabis producer in the Canadian marijuana industry is now a shell of its former self. Instead of acquiring large cannabis compani...
The marijuana industry has been significantly hindered by Section 280E of the IRS Code , which prevents businesses dealing with substances listed in Schedules 1 and 2 of the Controlled Substances Act (CSA) from deducting regular business expenses. Although Section 280E affects federal deductio...